The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pimozide-Global Market Insights and Sales Trends 2025
Synopsis
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global Pimozide market size is expected to reach US$ 10 million by 2029, growing at a CAGR of -0.9% from 2023 to 2029. The market is mainly driven by the significant applications of Pimozide in various end use industries. The expanding demands from the Hospitals, Drugstores and Others,, are propelling Pimozide market. 1Mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 2Mg segment is estimated at % CAGR for the next seven-year period.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pimozide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pimozide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pimozide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pimozide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pimozide covered in this report include Teva, Par Pharmaceutical, Johnson & Johnson, Eumedica, Pharmascience, Domina Pharmaceuticals and Aa Pharma, etc.
The global Pimozide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Global Pimozide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pimozide market, Segment by Type:
1Mg
2Mg
4Mg
Global Pimozide market, by Application
Hospitals
Drugstores
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pimozide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pimozide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global Pimozide market size is expected to reach US$ 10 million by 2029, growing at a CAGR of -0.9% from 2023 to 2029. The market is mainly driven by the significant applications of Pimozide in various end use industries. The expanding demands from the Hospitals, Drugstores and Others,, are propelling Pimozide market. 1Mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 2Mg segment is estimated at % CAGR for the next seven-year period.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pimozide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pimozide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pimozide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pimozide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pimozide covered in this report include Teva, Par Pharmaceutical, Johnson & Johnson, Eumedica, Pharmascience, Domina Pharmaceuticals and Aa Pharma, etc.
The global Pimozide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Global Pimozide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pimozide market, Segment by Type:
1Mg
2Mg
4Mg
Global Pimozide market, by Application
Hospitals
Drugstores
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pimozide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pimozide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Pimozide Market Overview
1.1 Pimozide Product Overview
1.2 Pimozide Market Segment by Type
1.2.1 1Mg
1.2.2 2Mg
1.2.3 4Mg
1.3 Global Pimozide Market Size by Type
1.3.1 Global Pimozide Market Size Overview by Type (2018-2029)
1.3.2 Global Pimozide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pimozide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pimozide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pimozide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pimozide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pimozide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pimozide Sales Breakdown by Type (2018-2023)
2 Global Pimozide Market Competition by Company
2.1 Global Top Players by Pimozide Sales (2018-2023)
2.2 Global Top Players by Pimozide Revenue (2018-2023)
2.3 Global Top Players by Pimozide Price (2018-2023)
2.4 Global Top Manufacturers Pimozide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pimozide Market Competitive Situation and Trends
2.5.1 Pimozide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pimozide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pimozide as of 2022)
2.7 Date of Key Manufacturers Enter into Pimozide Market
2.8 Key Manufacturers Pimozide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pimozide Status and Outlook by Region
3.1 Global Pimozide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pimozide Historic Market Size by Region
3.2.1 Global Pimozide Sales in Volume by Region (2018-2023)
3.2.2 Global Pimozide Sales in Value by Region (2018-2023)
3.2.3 Global Pimozide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pimozide Forecasted Market Size by Region
3.3.1 Global Pimozide Sales in Volume by Region (2024-2029)
3.3.2 Global Pimozide Sales in Value by Region (2024-2029)
3.3.3 Global Pimozide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pimozide by Application
4.1 Pimozide Market Segment by Application
4.1.1 Hospitals
4.1.2 Drugstores
4.1.3 Others
4.2 Global Pimozide Market Size by Application
4.2.1 Global Pimozide Market Size Overview by Application (2018-2029)
4.2.2 Global Pimozide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pimozide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pimozide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pimozide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pimozide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pimozide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pimozide Sales Breakdown by Application (2018-2023)
5 North America Pimozide by Country
5.1 North America Pimozide Historic Market Size by Country
5.1.1 North America Pimozide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pimozide Sales in Volume by Country (2018-2023)
5.1.3 North America Pimozide Sales in Value by Country (2018-2023)
5.2 North America Pimozide Forecasted Market Size by Country
5.2.1 North America Pimozide Sales in Volume by Country (2024-2029)
5.2.2 North America Pimozide Sales in Value by Country (2024-2029)
6 Europe Pimozide by Country
6.1 Europe Pimozide Historic Market Size by Country
6.1.1 Europe Pimozide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pimozide Sales in Volume by Country (2018-2023)
6.1.3 Europe Pimozide Sales in Value by Country (2018-2023)
6.2 Europe Pimozide Forecasted Market Size by Country
6.2.1 Europe Pimozide Sales in Volume by Country (2024-2029)
6.2.2 Europe Pimozide Sales in Value by Country (2024-2029)
7 Asia-Pacific Pimozide by Region
7.1 Asia-Pacific Pimozide Historic Market Size by Region
7.1.1 Asia-Pacific Pimozide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pimozide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pimozide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pimozide Forecasted Market Size by Region
7.2.1 Asia-Pacific Pimozide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pimozide Sales in Value by Region (2024-2029)
8 Latin America Pimozide by Country
8.1 Latin America Pimozide Historic Market Size by Country
8.1.1 Latin America Pimozide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pimozide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pimozide Sales in Value by Country (2018-2023)
8.2 Latin America Pimozide Forecasted Market Size by Country
8.2.1 Latin America Pimozide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pimozide Sales in Value by Country (2024-2029)
9 Middle East and Africa Pimozide by Country
9.1 Middle East and Africa Pimozide Historic Market Size by Country
9.1.1 Middle East and Africa Pimozide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pimozide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pimozide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pimozide Forecasted Market Size by Country
9.2.1 Middle East and Africa Pimozide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pimozide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Pimozide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Pimozide Products Offered
10.1.5 Teva Recent Development
10.2 Par Pharmaceutical
10.2.1 Par Pharmaceutical Company Information
10.2.2 Par Pharmaceutical Introduction and Business Overview
10.2.3 Par Pharmaceutical Pimozide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Par Pharmaceutical Pimozide Products Offered
10.2.5 Par Pharmaceutical Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Pimozide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Johnson & Johnson Pimozide Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Eumedica
10.4.1 Eumedica Company Information
10.4.2 Eumedica Introduction and Business Overview
10.4.3 Eumedica Pimozide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eumedica Pimozide Products Offered
10.4.5 Eumedica Recent Development
10.5 Pharmascience
10.5.1 Pharmascience Company Information
10.5.2 Pharmascience Introduction and Business Overview
10.5.3 Pharmascience Pimozide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pharmascience Pimozide Products Offered
10.5.5 Pharmascience Recent Development
10.6 Domina Pharmaceuticals
10.6.1 Domina Pharmaceuticals Company Information
10.6.2 Domina Pharmaceuticals Introduction and Business Overview
10.6.3 Domina Pharmaceuticals Pimozide Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Domina Pharmaceuticals Pimozide Products Offered
10.6.5 Domina Pharmaceuticals Recent Development
10.7 Aa Pharma
10.7.1 Aa Pharma Company Information
10.7.2 Aa Pharma Introduction and Business Overview
10.7.3 Aa Pharma Pimozide Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Aa Pharma Pimozide Products Offered
10.7.5 Aa Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pimozide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pimozide Industrial Chain Analysis
11.4 Pimozide Market Dynamics
11.4.1 Pimozide Industry Trends
11.4.2 Pimozide Market Drivers
11.4.3 Pimozide Market Challenges
11.4.4 Pimozide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pimozide Distributors
12.3 Pimozide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
